News & Updates

Innovative therapies and individualized care are key to managing hypertension and AF

The "Fight for Freedom: Joining Forces Against Cardiovascular Disease" symposium brought together key figures in cardiology to discuss the growing burden of cardiovascular disease (CVD) in the Philippines. Notable speakers included Dr Gilbert C. Vilela, an Examiner for the Philippine Board of Cardiology, and Dr Eugenio B. Reyes, Past President of the Philippine Heart Association. The event highlighted two of the most pressing cardiovascular challenges in the country today: hypertension and atrial fibrillation (AF).

Diabetes Mellitus Type II DMT2 Vildagliptin

Product Highlight - Dapagliflozin (Forxiga)

Film-Coated Tablet 10 mg

Product Highlight - Vericiguat (Verquvo)

Film-Coated Tablet 2.5 mg, 5 mg, and 10 mg

Product Highlight - Apixaban (Embolis 2.5/Embolis 5)

Film-Coated Tablet 2.5 mg and 5 mg

Be updated with the developments in incretin-based treatment for diabetes

[ Incretin Odyssey ]

Debunking the myths about DPP-4 inhibitors

Navigating the evolving landscape of diabetes management requires precise knowledge. In this exploration into the world of DPP-4 inhibitors (DPP4is), we aim to debunk prevalent myths and provide nuanced insights.

Revisiting the GIP hormone

[ Dr. Augusto Litonjua ]

Product Highlight - Apixaban (Embolis 2.5/Embolis 5)

Film-Coated Tablet 2.5 mg and 5 mg

Product Highlight - Telmisartan, Amlodipine Besilate (Mistacor AM)

Tablet 40 mg/5 mg, 40 mg/10 mg, 80 mg/5 mg and 80 mg/10 mg